Pilot Award Recipient: Jose Bordon, PhD
The introduction of combination anti-retroviral therapy (ART) resulted in dramatic reductions in AIDS-related mortality and improvements in the prognosis for HIV-infected patients.
The DC CFAR has funded a wide variety of research, including basic, clinical, epidemiologic, social behavioral and prevention HIV/AIDS science since 2017.
Pilot Award Recipient: Jose Bordon, PhD
The introduction of combination anti-retroviral therapy (ART) resulted in dramatic reductions in AIDS-related mortality and improvements in the prognosis for HIV-infected patients.
Pilot Award Recipient: Ian Toma, PhD, MD
The project is aimed at identification of transcripts (genes) differentially expressed in the umbilical cord blood of neonates born to HIV infected and uninfected women.
Pilot Award Recipient: Dana Hines, PhD, MSN, BSN
Transgender people account for an estimated 2.8% of the population in the District of Columbia (DC), however, account for approximately 2% of the population living with HIV.
Pilot Award Recipient: Deborah Goldstein, MD
The transfemale community, and especially transwomen of color, in Washington, DC bear a disproportionate burden of HIV infection.
Pilot Award Recipient: Richard Apps, PhD
Over the past decade HLA-C, the least polymorphic classical HLA class-I molecule, has been found to influence HIV-1 disease.
Pilot Award Recipient: Raymond Scott Turner, PhD
Despite significant advances in medical treatment, approximately half of patients with HIV-infection are affected by reduced brain functions.
Pilot Award Recipient: Leah Squires, PhD
The goal of this study is to find out if a short questionnaire can identify men who have experienced intimate partner violence (IPV).
Pilot Award Recipient: Marina Jerebtsova, PhD
In HIV-infected patients on antiretroviral therapy pulmonary complications have been shifted from opportunistic infections to non-communicable disease.
Pilot Award Recipient: Sarah Calabrese, PhD
This one year pilot pilot award will study PrEP social marketing to Black MSM in Washington, DC.
Pilot Award Recipient: Jeffrey Bethony, MD, PhD
This one year pilot study explores recent advances in HIV vaccines that focus on inducing “broadly neutralizing antibodies” (bNAbs).